AU Patent
AU2002361185A1 — Use of (+)-(1s,2s)-3-(3-dimethylamino-1-ethyl-2-methyl-propyl)phenol as anti-emetic agent
Assigned to Gruenenthal GmbH · Expires 2003-07-09 · 23y expired
What this patent protects
Patent listed against Barhemsys.
Drugs covered by this patent
- Barhemsys (AMISULPRIDE) · Acacia
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.